The short version of pentapeptide fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-09-05. Anything still debated is marked as such rather than presented as settled.
Structural features distinguish the molecule from earlier secretagogues. An alpha-aminoisobutyric acid residue near the N-terminus and a D-naphthylalanine substitution increase receptor affinity, while C-terminal amidation improves resistance to exopeptidases. These modifications are associated with reduced stimulation of appetite and of the hypothalamic-pituitary-adrenal axis compared with hexarelin or growth hormone releasing peptide-6. Whether the same profile applies at every dose level studied is a matter of ongoing investigation rather than settled consensus.
Ipamorelin is a synthetic pentapeptide that acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. Its sequence incorporates non-natural residues, which slows enzymatic breakdown relative to short native peptides. In laboratory and early clinical work the compound is described as a selective growth hormone secretagogue because it raises growth hormone with comparatively little effect on other pituitary outputs. The degree to which that selectivity holds across species and dosing regimens remains an open question in the published literature.
Signal transduction begins when the peptide binds GHSR-1a on pituitary somatotrophs. The receptor couples to Gq/11 proteins, activating phospholipase C, which cleaves phosphatidylinositol bisphosphate into inositol trisphosphate and diacylglycerol. Inositol trisphosphate releases calcium from intracellular stores, and the resulting rise in cytosolic calcium drives growth hormone vesicle fusion. Concurrent Gs coupling and cyclic AMP elevation have also been reported, and the relative contribution of each arm to the overall secretory response is not fully settled.
从用途定位看，ipamorelin 目前主要以研究用肽的身份被讨论，未见主要药品监管机构将其批准为治疗药物。市售材料通常标注仅供研究使用，不得用于人体或诊断程序。文献中它常与生长激素促分泌素、GHS-R1a 激动剂、胃饥饿素拟似物等表述并列出现。既有研究的样本量普遍偏小，因此对其效应强度与一致性的描述应保持谨慎。
Ipamorelin 是一种合成五肽，序列为 Aib-His-D-2-Nal-D-Phe-Lys-NH2，分子式 C38H49N9O5，游离碱分子量约 711.85 g/mol。它属于生长激素促分泌素（GHS）家族，作用靶点是胃饥饿素受体 GHS-R1a。该化合物由诺和诺德的研究团队在二十世纪九十年代末报道，设计目标是提高对生长激素释放的选择性。C 端酰胺化与 N 端 Aib 残基是两个用于抵抗肽酶降解的结构特征。
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H49N9O5 | Reported for the free peptide |
| Molecular mass | 711.85 Da | Monoisotopic value |
| Residue motif | Aib-His-D-2-Nal-D-Phe-Lys-NH2 | Non-natural residues at positions one and three |
| Primary target | GHSR-1a | Ghrelin receptor, G protein coupled |
| Reported plasma half-life | About two hours | Values vary with assay and subject group |
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor type 1a, the same G protein-coupled receptor that binds ghrelin. Receptor activation couples to Gq/11 signaling, raising intracellular calcium through inositol trisphosphate and diacylglycerol, which in turn promotes exocytosis of growth hormone from pituitary somatotroph cells. Ipamorelin binds this receptor with high affinity and shows weak activity at other secretagogue-related targets in vitro. Its action requires the intact receptor and is not reversed by growth hormone-releasing hormone antagonists.
Compared with earlier growth hormone secretagogues such as GHRP-6 and hexarelin, ipamorelin has been reported to produce less stimulation of adrenocorticotropic hormone, cortisol, and prolactin in animal and early human studies. This selectivity is usually attributed to differences in receptor subtype interactions and to the tissue distribution of the receptor. Effects on appetite appear weaker than those of ghrelin itself, although the supporting evidence base is small. Whether these differences produce a distinct clinical profile remains an open question, since controlled human trials are limited.
Ipamorelin is a synthetic pentapeptide first described in the 1990s by researchers at Novo Nordisk during a program to develop selective growth hormone secretagogues. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues, alpha-aminoisobutyric acid and D-2-naphthylalanine. The C-terminus is amidated, and the material is supplied as a white lyophilized powder. The molecular formula is C38H49N9O5 and the monoisotopic mass is approximately 711.85 daltons. The short chain and modified residues give it greater resistance to enzymatic degradation than many larger peptide hormones.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, and its molecular mass is approximately 711.9 daltons. The compound was described in the late 1990s by researchers seeking molecules that release growth hormone with fewer side effects than earlier secretagogues. It is a laboratory and research compound, not an approved medicine in most jurisdictions.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor, also called the ghrelin receptor or GHS-R1a. Binding to this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to growth hormone release. The effect is mediated through phospholipase C and calcium mobilization rather than through the cyclic AMP pathway used by growth hormone releasing hormone. The two pathways are complementary, and combined stimulation produces a larger response than either alone.
== Nasal drugs == The area of intranasal medication delivery provides a huge opportunity for research – both for specifically developed pharmaceutical drugs designed for intranasal treatment, as well as for investigating off-label uses of commonly available generic medications. Steroids, and a large number of inhalational anaesthetic agents are being used commonly. The recent developments in intranasal drug delivery systems are prodigious. Peptide drugs (hormone treatments) are also available as nasal sprays, in this case to avoid drug degradation after oral administration. The peptide analogue desmopressin is, for example, available for both nasal and oral administration, for the treatment of diabetes insipidus. The bioavailability of the commercial tablet is 0.1% while that of the nasal spray is 3-5% according to the SPC (Summary of Product Characteristics). Intranasal calcitonin, calcitonin-salmon, is used to treat hypercalcaemia arising out of malignancy, Paget's disease of bone, post menopausal and steroid induced osteoporosis, phantom limb pain and other metabolic bone abnormalities, available as Rockbone, Fortical and Miacalcin Nasal Spray. GnRH analogues like nafarelin and busurelin are used for the treatment of anovulatory infertility, hypogonadotropic hypogonadism, delayed puberty and cryptorchidism. Other potential drug candidates for nasal administration include anaesthetics, antihistamines (Azelastine), antiemetics (particularly metoclopramide and ondansetron) and sedatives that all benefit from a fast onset of effect.
== Chemical properties == Trisulfuryl fluoride is a reactive compound. It is known to decompose into disulfuryl fluoride when heated. The compound reacts with certain compounds, like the sodium cyanohydrin salt, to form other fluorosulfates. It slowly hydrolizes in the solution of potassium hydroxide (KOH):
Stock, sometimes called bone broth, is a savory cooking liquid that forms the basis of many dishes – particularly soups, stews, and sauces. Making stock involves simmering animal bones, meat, seafood, or vegetables in water or wine, often for an extended period. Mirepoix or other aromatics may be added for more flavor.
When cyclopentadiene is used as the diene, the vicinal norbornene diol bicyclo[2.2.1]hept-5-ene-2,3-diol is formed after hydrolysis. The Swern oxidation to the 1,2-ketone bicyclo[2.2.1]hept-5-ene-2,3-dione proceeds (in the variant with trifluoroacetic anhydride instead of oxalyl chloride) with a yield of 73%.
Supreme Court, chief judge of the United States Court of Appeals for the Second Circuit, judge of the United States District Court for the Southern District of New York Ogden Hoffman Jr. (1840), judge on the United States District Court for the Northern District of California William Colford Schermerhorn (1840), lawyer, philanthropist, trustee of Columbia University Peter B. Sweeny* (1840s), New York County district attorney in 1858 Alexander McCue (1845), solicitor of the United States Treasury 1885–1888 Joseph Larocque (1849), attorney; president of the New York City Bar Association Frederic René Coudert Sr. (1850), lawyer, founder of international law firm Coudert Brothers Myer J. Newmark* (1850s), youngest city attorney in the history of Los Angeles Elbridge Thomas Gerry (1857), lawyer and social reformer who founded the New York Society for the Prevention of Cruelty to Children; grandson of U.S. Vice President Elbridge Gerry Gabriel Mead Tooker (1859), lawyer and clubman, father in law of Whitney Warren of architectural firm Warren and Wetmore Edgar M.
Sources: en.wikipedia.org
=== Bacterial colonization === Since more oxygen in the wound environment allows white blood cells to produce ROS to kill bacteria, patients with inadequate tissue oxygenation, for example those who developed hypothermia during surgery, are at higher risk for infection. The host's immune response to the presence of bacteria prolongs inflammation, delays healing, and damages tissue. Infection can lead not only to chronic wounds but also to gangrene, loss of the infected limb, and death of the patient. More recently, an interplay between bacterial colonization and increases in reactive oxygen species leading to formation and production of biofilms has been shown to generate chronic wounds. Like ischemia, bacterial colonization and infection damage tissue by causing a greater number of neutrophils to enter the wound site. In patients with chronic wounds, bacteria with resistances to antibiotics may have time to develop. In addition, patients that carry drug resistant bacterial strains such as methicillin-resistant Staphylococcus aureus (MRSA) have more chronic wounds.
587,000 m² of built-up industrial and logistics space, with 93,000 m² dedicated to cold storage. 250,000 m² of warehousing capacity under development with AED 621 million investment. Serviced plots, cold storage units, light industrial units, and startup-ready facilities.
== Treatment == There is no cure for vitiligo but several treatment options are available, including topical medication and ultraviolet light, or a combination of the two, although phototherapy may pose a risk of skin cancer. According to one study, lesions on the hands, feet, and joints are the most difficult to repigment; those on the face are easiest to return to the natural skin color as the skin is thinner.
Since the species is only found in remnant populations in the Wallacean Island, studies have examined the traits and factors that led to these certain populations' surprising persistence. A comprehensive examination of the species survival suggested that rather than being a single attribute, but the a combination including ectotherm traits, varanid biology, habitat, and anthropogenic factors.
Sources: en.wikipedia.org
== Domestic commercialisation == Texturas is a range of products by Ferran Adrià, and his brother Albert Adrià. The products include the Sferificación, Gelificación, Emulsificación, Espesantes and Surprises lines. Texturas include products such as Xanthan and Algin which are packaged and labelled as Xantana Texturas and Algin Texturas respectively. Xanthan gum allows the user to use a very small amount to thicken soups, sauces and creams without changing the flavour. Algin is a key component of the "Spherification Kit" and is used for every spherical preparation: caviar, raviolis, balloons, gnocchi, pellets, and mini-spheres.
==== MeSH D13.570.800 – ribonucleosides ==== MeSH D13.570.800.096 – adenosine MeSH D13.570.800.096.250 – adenosine-5'-(n-ethylcarboxamide) MeSH D13.570.800.096.262 – s-adenosylhomocysteine MeSH D13.570.800.096.264 – s-adenosylmethionine MeSH D13.570.800.096.300 – 2-chloroadenosine MeSH D13.570.800.096.300.200 – cladribine MeSH D13.570.800.096.500 – isopentenyladenosine MeSH D13.570.800.096.630 – phenylisopropyladenosine MeSH D13.570.800.286 – cytidine MeSH D13.570.800.286.300 – azacitidine MeSH D13.570.800.330 – dichlororibofuranosylbenzimidazole MeSH D13.570.800.410 – formycins MeSH D13.570.800.410.200 – coformycin MeSH D13.570.800.453 – guanosine MeSH D13.570.800.453.500 – nucleoside q MeSH D13.570.800.573 – inosine MeSH D13.570.800.573.130 – didanosine MeSH D13.570.800.573.450 – inosine pranobex MeSH D13.570.800.573.900 – thioinosine MeSH D13.570.800.573.900.500 – methylthioinosine MeSH D13.570.800.790 – ribavirin MeSH D13.570.800.810 – showdomycin MeSH D13.570.800.840 – toyocamycin MeSH D13.570.800.850 – tubercidin MeSH D13.570.800.892 – uridine MeSH D13.570.800.892.176 – azauridine MeSH D13.570.800.892.250 – 3-deazauridine MeSH D13.570.800.892.628 – pseudouridine MeSH D13.570.800.892.800 – tetrahydrouridine MeSH D13.570.800.892.829 – thiouridine
The Life Sciences Institute (LSI) is a collaborative, multidisciplinary research institution located on the campus of the University of Michigan in Ann Arbor. It encompasses 27 faculty-led teams from 13 schools and departments throughout U-M. Of the university's $823 million in research expenditures, more than half is allocated for research in the life sciences, and the LSI is a cornerstone of this effort.
Sources: en.wikipedia.org
Both molecules activate the same receptor, GHSR-1a, but they share little sequence identity. Ghrelin is a 28-amino-acid hormone carrying a distinctive acyl modification, whereas ipamorelin is a short synthetic peptide. The shared target explains overlapping endocrine effects, while the different structures account for differences in metabolic stability and receptor selectivity.
Early animal and human studies reported growth hormone release at levels that produced small changes in cortisol, prolactin and adrenocorticotropic hormone. That contrast with older secretagogues gave rise to the selectivity label. The observation is consistent across several reports but rests on a limited number of small studies.
Plasma peptidases cleave the molecule into smaller fragments, and reported half-lives in human studies are on the order of a couple of hours. The identity and activity of individual breakdown products have not been fully mapped. Questions about tissue-level clearance remain open.
两者都是 GHS-R1a 激动剂，但 ipamorelin 在研究中显示出更高的生长激素释放选择性。早期资料显示它对皮质醇、催乳素与食欲的刺激弱于 GHRP-6。这些差异是相对程度，而非绝对区分。